Table 1.

Baseline characteristics for all 16 patients enrolled on study

Median (range)
Gender12 male/4 female
Untreated12/16 (75%)
Age (y)65 (49-85)
Prior therapies0 (0-2)
Bone marrow involvement (%)37.5 (5-90)
Serum IgM (mg/dL)4,000 (1,180-7,130)
β2-Microglobulin (mg/L)3.3 (1.8-6)
Hematocrit (%)32.1 (24-36.6)
Platelets (k/μL)282.5 (78-568)
Leukocytes (k/μL)6.05 (3-22)